Post by
davewho on Dec 08, 2020 9:41am
CC
now open for replay.
Q1 is mentioned quite a few times by James during the call.
Comment by
frewil11 on Dec 08, 2020 9:50am
Investors were looking for news or information regarding a signing or partnerships with a large health care company or something along that line.
Comment by
VerifiedUser123 on Dec 08, 2020 9:52am
Precisely. By saying fluff, Tripp gives a wide birth of not being held to account by exact deliverables.
Comment by
tallguy on Dec 08, 2020 9:53am
Not the CC I was expecting. I was expecting at the least few numbers. How many tests they do every day, money coming in etc...Nothing of that. Down 2 cents alreaday and the day is just beginning. Another 3 months to wait. This thing will never see the dollar this year. What a waste of time.
Comment by
davewho on Dec 08, 2020 10:03am
revisit slide 12 $18m to $31m US rev in covid testing for the next 9 - 12 months
Comment by
Bully88 on Dec 08, 2020 10:05am
Q3 $1,600,000 revenue Q3 $900,000 Burn rate Q3 Profit Margins 56% Love it Cheers, Bully
Comment by
davewho on Dec 08, 2020 10:23am
thats a lot of $ for marketing Aristotle. If Aristotle is a huge success on roll out it will also add to rev in 2021. IMO Someone still wants a whole bunch of WS series today at 20 cents. Latest bid has moved up to 21. Doesn't appear to be many sellers at the moment.
Comment by
LithLover on Dec 08, 2020 10:42am
I saw a post on the weekendd that showed only 4 million of the WS warrants vs 70 million of the WT warrants.. So they are not liquid at all and would be very difficult to try and trade. They are definately a buy and hold into dollars so people buying would need to be able to hold for months/years and in the event of a change or buy out be in a position to exercise at $1.10 a share.